Filing Details

Accession Number:
0000950170-25-031123
Form Type:
13D Filing
Publication Date:
2025-03-02 19:00:00
Filed By:
BT DE Investments Inc.
Company:
Organigram Holdings Inc. (NASDAQ:OGI)
Filing Date:
2025-03-03
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
BT DE Investments Inc. 0 40,134,389 0 40,134,389 40,134,389 30%
British American Tobacco p.l.c. 0 40,134,389 0 40,134,389 40,134,389 30%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
Row 13 is based on 133,781,297 Common Shares, no par value ("Common Shares"), of Organigram Holdings Inc. (the "Issuer"), comprised of 126,218,850 Common Shares outstanding immediately prior to completion of the Third Tranche (as defined below) and after giving effect to the issuance of 7,562,447 Common Shares in the Third Tranche. Following the completion of the Third Tranche on February 28, 2025, the Reporting Person beneficially owned 40,134,389 Common Shares and 13,794,163 Preferred Shares (as defined below), representing 30% of the issued and outstanding Common Shares and 100% of the Preferred Shares, in each case on a non-diluted basis.


SCHEDULE 13D



Comment for Type of Reporting Person:
Row 13 is based on 133,781,297 Common Shares, comprised of 126,218,850 Common Shares outstanding immediately prior to completion of the Third Tranche and after giving effect to the issuance of 7,562,447 Common Shares in the Third Tranche. Following the completion of the Third Tranche on February 28, 2025, the Reporting Person beneficially owned 40,134,389 Common Shares and 13,794,163 Preferred Shares, representing 30% of the issued and outstanding Common Shares and 100% of the Preferred Shares, in each case on a non-diluted basis.


SCHEDULE 13D

 
BT DE Investments Inc.
 
Signature:/s/ Chris Voelker
Name/Title:Chris Voelker, General Counsel
Date:03/03/2025
 
British American Tobacco p.l.c.
 
Signature:/s/ Caroline Ferland
Name/Title:Caroline Ferland, Secretary
Date:03/03/2025